Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
05/2007
05/29/2007US7223410 Inactivated respiratory syncytial viral vaccines
05/29/2007US7223409 Nucleic acid linked to a mammalian expression promoter that is suitable for producing and expressing capside, E1, E2, E3 and 6K structural proteins encoded by the 26S genomic virus RNA.
05/29/2007US7223407 Immunogens; water-in-oil emulsions; oil-in-water emulsions; vaccines; freeze drying
05/29/2007US7223389 Compositions and methods for treatment of cancer
05/29/2007CA2262476C Viral vectors and their uses
05/24/2007WO2007059473A2 Methods for the production and purification of adenoviral vectors
05/24/2007WO2007058527A2 Inducible expression systems
05/24/2007WO2007057763A2 Nitric oxide as an anti-viral agent, vaccine and vaccine adjuvant
05/24/2007WO2007057062A1 Human bocavirus and methods of diagnosis and treatment
05/24/2007WO2007056847A1 Stabilizing formulations for recombinant viruses
05/24/2007WO2005112622A3 Regulation of transcription with a cis-acting ribozyme
05/24/2007US20070117189 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
05/24/2007US20070117131 Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process
05/24/2007US20070117129 Antigen arrays for treatment of bone disease
05/24/2007US20070116718 Fusion proteins comprising bacteriophage coat protein and asingle-chain T cell receptor
05/24/2007CA2630349A1 Stabilizing formulations for recombinant viruses
05/24/2007CA2630348A1 Inducible expression systems
05/24/2007CA2629786A1 Human bocavirus and methods of diagnosis and treatment
05/23/2007EP1786904A2 Adenoviral vector compositions
05/23/2007EP1244912B1 Methods for screening or evaluating the performance of a set of biological agents in living target cells and their uses
05/23/2007EP1056881B1 A simplified system for generating recombinant adenoviruses
05/23/2007EP0754223B1 Non-pathogenic strains of hiv-1
05/23/2007CN1317387C Fast donor plasmid carrying cotton bollworm single particle embedded nuclear polyhedrosis virus gene and P10 gene promotor sequence and construction method
05/22/2007US7220852 For diagnosis, therapy
05/22/2007US7220577 Modified AAV
05/22/2007US7220419 Self-assembling recombinant papillomavirus capsid proteins
05/22/2007CA2279062C Process and agent for the sanitization of contaminations caused by viruses
05/22/2007CA2217882C European vaccine strains of the porcine reproductive and respiratory syndrome virus (prrsv)
05/18/2007WO2007054297A2 Use of hydrophobic interaction chromatography for the attenuation of viruses
05/17/2007US20070112174 Screening; peptide, bacteriophage, artificial protein or chimeric molecule having binding ability to titanium, silver, silicon; expressing library of peptide sequences, recovering titanium bound to phage particles via peptide sequence by centrifuging; proliferation in bacteria, cloning, concentrating
05/17/2007US20070111957 Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof
05/17/2007US20070111296 Methods and Devices for Quantitative Viral Assays
05/17/2007US20070111295 Method of Producing Baculovirus
05/17/2007US20070111211 Integrated viral complexes, methods of production thereof, vaccines containing same and methods of use thereof
05/17/2007US20070110724 DNA viral plasmid for use as gene transfer tool in genetic engineering and genic therapy; improved exogenous transcriptional expression
05/17/2007US20070110720 Vectors, mutant viruses and methods for generating mutant viruses
05/16/2007EP1785495A1 Detection of bovine viral darrhea virus in tissue samples
05/16/2007EP1784487A2 Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use
05/16/2007EP1119617B1 Fusions of scaffold proteins with random peptide libraries
05/16/2007EP0920491B1 Immortalized cell lines for virus growth
05/15/2007US7217866 Isolated senescence-induced deoxyhypusine synthase encoded by a nucleotide sequence which hybridizes under low stringency condition with preferred nucleic acid sequence
05/15/2007US7217807 Human immunodeficiency viral nucleotide sequences for use as gene therapeutic tools in prevention of viral infection; gene expression inhibition
05/15/2007US7217793 Protein for use in the diagnosis, treatment and prevention of nervous system disorders; low cytotoxicity; specifically recognizes sphingomyelin from Lysenin variants
05/15/2007US7217419 Vaccine for preventing cervical cancer
05/15/2007US7217418 Administering an attenuated dengue-1 (DEN-1) virus composition
05/15/2007CA2515166C Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome
05/15/2007CA2249736C Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection
05/15/2007CA2094705C Pharmaceutical composition for treating or preventing malign tumors
05/10/2007WO2007053188A2 Production of multivalent virus like particles
05/10/2007WO2006105597A8 Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof
05/10/2007US20070107069 Animal model having a chimeric human liver
05/10/2007US20070106062 Attenuated vif DNA immunization cassettes for genetic vaccines
05/10/2007US20070105219 Retrovirus from the HIV group and its use
05/10/2007US20070105208 Minus strand rna virus vector carrying gene modified in high mutation region
05/10/2007US20070105093 Uncoupling of DNA insert propagation and expression of protein for phage display
05/10/2007US20070104734 Recombinant viruses with heterologous envelope proteins
05/10/2007US20070104732 Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism
05/10/2007CA2608515A1 Production of multivalent virus like particles
05/09/2007EP1783218A1 Hcv rna having novel sequence
05/09/2007EP1783212A1 Methods of adenovirus purification
05/09/2007EP1783211A1 Hbv particles containing hbv-rna
05/09/2007EP1783138A1 Method of purifying virus envelope
05/09/2007EP1781778A1 Multichemistry fractionation
05/09/2007EP1478759B1 Retroviral vectors pseudotyped with influenza virus hemagglutinin and influenza m2 potein for gene delivery
05/09/2007EP1137792B1 A recombinant vector expressing multiple costimulatory molecules and uses thereof
05/09/2007EP1012244B1 Rhabdoviruses with reengineered coats
05/09/2007CN1961001A Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
05/09/2007CN1958788A Gene recombined virus of human neurenergen 3
05/08/2007US7214524 Marek's disease virus vaccine
05/08/2007US7214368 Therapeutic regimen for treating cancer comprising the administration of adenoviral vectors comprising a TNF-α transgene
05/08/2007CA2293612C Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor
05/08/2007CA2236968C Accessory functions for use in recombinant aav virion production
05/03/2007WO2007050074A1 Conditionally replicating viruses and methods for cancer virotherapy
05/03/2007WO2007049409A1 Recombinant hsv useful for treatment of human glioma
05/03/2007WO2006113550A3 Viral nucleoprotein detection using an ion channel switch biosensor
05/03/2007WO2006017276A3 Recombinant rabies virus compositions
05/03/2007WO2005092069A8 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
05/03/2007US20070099262 Viral vectors expressing fusion of viral large envelope protein and protein of interest
05/03/2007US20070099179 Method for inducing hepatitis c virus (hcv) replication in vitro, cells and cell lines enabling robust hcv replication and kit therefor
05/03/2007US20070098743 a mutant rhabdovirus having one or more mutation in a gene encoding a protein involved in blocking nuclear transport of mRNA or protein in an infected cells; capable of triggering the anti-viral systems of normal host cells; anticarcinogenic agent; vaccine adjuvant, vaccine vector
05/03/2007US20070098742 For inducing an immune response to the influenza virus in canines, veterinary medicine
05/03/2007US20070098691 Binding site amino acid sequences for use as targeting agents in immunotherapeutics; antitumor agents; which conforms to human leukocyte antigen (HLA) motifs; immunogens; cytotoxic T lymphocytes; comprises proteases; prostate cancer
05/03/2007US20070098689 Mutant viruses
05/03/2007CA2627638A1 Conditionally replicating viruses and methods for cancer virotherapy
05/03/2007CA2627463A1 Anti mineralocorticoid therapy of infection
05/02/2007EP1780285A1 Improved virus like particles (VLP) based on the small envelope protein of hepatitis B virus (HBsAg-S)
05/02/2007EP1780269A2 Virus purification methods
05/02/2007EP1780217A1 Molecular structure of RHD negative locus
05/02/2007EP1780216A1 Pantropic canine coronavirus
05/02/2007EP1778295A1 Gene therapy of solid tumours by means of retroviral vectors pseudotyped with arenavirus glycoproteins
05/02/2007EP1346058B1 Adenoviral systems and the uses thereof
05/02/2007CN1313605C Gene recombinant fowl influenza virus D3/F-R2/6 and its construction method
05/02/2007CN1313604C Recombined rhabdovirus containing double valence insect resisting gene
05/01/2007US7211659 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
05/01/2007US7211432 Foreign nucleic acid molecule encoding multiple costimulatory molecules, such as B7-1 or B7-2 (antigents), intercellular adhesion molecules and leukocyte function associated antigen-3
05/01/2007US7211426 isolated phage from the Myoviridae family having a genome size of 170 kb and lytic activity against pathogenic E. coli or Salmonella strainsin used in particular for phage therapy of pediatric gastroenteritis or Salmonella infection
05/01/2007US7211379 Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
05/01/2007US7211378 Promoter linked to DNA segment, which upon being transcribed yields a RNA which is capable of being packaged into virions or replicated in the presence of proteins; lipid encapsulation
05/01/2007US7211260 Infectious bursitis vaccine
05/01/2007CA2192215C Recombinant aav genome encoding immunodeficiency virus protein